Free Trial
CVE:NDVA

Indiva (NDVA) Stock Price, News & Analysis

Indiva logo
C$0.03 -0.01 (-14.29%)
As of 06/12/2024

About Indiva Stock (CVE:NDVA)

Key Stats

Today's Range
C$0.03
C$0.04
50-Day Range
C$0.03
C$0.03
52-Week Range
C$0.02
C$0.13
Volume
558,384 shs
Average Volume
119,038 shs
Market Capitalization
C$5.86 million
P/E Ratio
N/A
Dividend Yield
4.04%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Indiva Limited engages in the production, processing, and sale of cannabis and cannabis related products in Canada. It offers pre-rolls, flower, capsules, and edible and extract products under the INDIVA, Indiva Life, and Artisan Batch brands. The company produces and distributes the Bhang Chocolate, Wana Sour Gummies, Jewels Chewable Tarts, Grön edibles, and Dime Industries vape products through license agreements and partnerships. Indiva Limited is based in Ottawa, Canada.

Receive NDVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Indiva and its competitors with MarketBeat's FREE daily newsletter.

NDVA Stock News Headlines

Indiva Ltd Average Daily Volume (3m)
The Silver Squeeze Is Already Here—Are You Ready?
A Silver Supply Crunch + Rising Demand = A Perfect Storm. Here's What You Need To Know
Indiva Limited (NDVA-H.V)
NDVA:CA Indiva Limited
See More Headlines

NDVA Stock Analysis - Frequently Asked Questions

Indiva's stock was trading at C$0.03 at the start of the year. Since then, NDVA shares have increased by 0.0% and is now trading at C$0.03.
View the best growth stocks for 2025 here
.

Shares of NDVA stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Indiva investors own include Meta Platforms (META), Canopy Growth (CGC), 22nd Century Group (XXII), AcelRx Pharmaceuticals (ACRX), Acasti Pharma (ACST), Curaleaf (CURLF) and Fortress Biotech (FBIO).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
CVE:NDVA
CIK
N/A
Fax
N/A
Employees
147,000
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
C$-4,920,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$37.57 million
Cash Flow
C$0.01 per share
Price / Cash Flow
5.20
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
C$5.86 million
Optionable
Not Optionable
Beta
1.12
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (CVE:NDVA) was last updated on 5/14/2025 by MarketBeat.com Staff
From Our Partners